Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
NCT05399992
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
847
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Hypercholesterolemia
Mixed Dyslipidemia
Interventions
OTHER:
Inclisiran
Sponsor
Novartis Pharmaceuticals